• home
• organisatie
• onderzoeksgroepen
• klinische partners
• publicaties
• contacteer ons
• zoek
• IBB steunen
• geschiedenis
• links
• lab only

Publicaties

IBB
Scientific Report 2010 (addendum I)	pdf
Lijst van publicaties IBB in 2011
Aerts I., Martin J.J., Deyn P.P., Van Ginniken C., Van Ostade X., Kockx M., Dua G., Slegers H. The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade. Clin. Neurol. Neurosurg. 113 (3):224-229 (2011)
Brouns R., Wauters A., De Surgeloose D., Mariën P., De Deyn P.P. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur. Neurol. 65 (1): 23-31 (2011)
Brouwers N., Van Cauwenberghe C., Engelborghs S., Lambert J.C., Bettens K., Le Bastard N., Pasquier F., Montoya A.G., Peeters K., Mattheijssens M., Vandenberghe R., De Deyn P.P., Cruts M., Amouyel P., Sleegers K., Van Broeckhoven C. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol. Psychiatry 2011 Mar 15; doi:10.1038/mp.2011.24
Chen-Plotkin A.S., Martinez-Lage M., Sleiman P.M., Hu W., Greene R., Wood E.M., Bing S., Grossman M., Schellenberg G.D., Hatanpaa K.J., Weiner M.F., White C.L. 3rd, Brooks W.S., Halliday G.M., Kril J.J., Gearing M., Beach T.G., Graff-Radford N.R., Dickson D.W.,Rademakers R., Boeve B.F., Pickering-Brown S.M., Snowden J., van Swieten J.C., Heutink P.,Seelaar H., Murrell J.R., Ghetti B., Spina S., Grafman J., Kaye J.A., Woltjer R.L., Mesulam M., Bigio E., Lladó A., Miller B.L., Alzualde A., Moreno F., Rohrer J.D., Mackenzie I.R., Feldman H.H., Hamilton R.L., Cruts M., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Bird T.D., Cairns N.J., Goate A., Frosch M.P., Riederer P.F., Bogdanovic N., Lee V.M., Trojanowski J.Q., Van Deerlin V.M. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch. Neurol. 68 (4): 488-497 (2011)
Claes S., Myint A.M., Domschke K., Del-Favero J., Entrich K., Engelborghs S., De Deyn P., Mueller N., Baune B., Rothermundt M. The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes. Psychiatry Res. 188 (3): 355-360 (2011)
De Deyn P.P., Eriksson H., Svensson H. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study. Int. J. Geriatr. Psychiatry 2011 Apr 27; doi: 10.1002/gps.2720
De Deyn P.P., Goeman J., Vervaet A., Dourcy-Belle-Rose B., Van Dam D., Geerts E. Prevalence and incidence of dementia among 75-80-year-old community-dwelling elderly in different districts of Antwerp, Belgium: The Antwerp Cognition (ANCOG) Study. Clin. Neurol. Neurosurg. 2011 Aug 20; doi:10.1016/j.clineuro.2011.07.030
De Smet H.J., Engelborghs S., Paquier P.F., De Deyn P.P., Mariën P. Cerebellar-induced apraxic agraphia: a review and three new cases. Brain Cogn. 76 (3): 424-434 (2011)
De Witte L., Brouns R., Kavadias D., Engelborghs S., De Deyn P.P., Mariën P. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: A review. Cortex 47 (3): 273-319 (2011)
Dierckx E., Engelborghs S., De Raedt R., De Deyn P.P., D'Haenens E., Verte D., Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer's disease and elderly depression: A cross-sectional pilot study. Aging Ment. Health 15 (1): 113-121 (2011)
Geeganage C., Tracy M., England T., Sare G., Moulin T., Woimant F., Christensen H., De Deyn P.P., Leys D., O'Neill D., Ringelstein E.B., Bath P.M.; for TAIST Investigators. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 42 (2): 491-493 (2011)
Genin E., Hannequin D., Wallon D., Sleegers K., Hiltunen M., Combarros O., Bullido M.J., Engelborghs S., De Deyn P., Berr C., Pasquier F., Dubois B., Tognoni G., Fiévet N., Brouwers N., Bettens K., Arosio B., Coto E., Del Zompo M., Mateo I., Epelbaum J., Frank-Garcia A., Helisalmi S., Porcellini E., Pilotto A., Forti P., Ferri R., Scarpini E., Siciliano G., Solfrizzi V., Sorbi S., Spalletta G., Valdivieso F., Vepsäläinen S., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Hanon O., Piccardi P., Annoni G., Seripa D., Galimberti D., Licastro F., Soininen H., Dartigues J.F., Kamboh M.I., Van Broeckhoven C., Lambert J.C., Amouyel P., Campion D. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16 (9): 903-907 (2011)
Gebruers N., Truijen S., Engelborghs S., De Deyn P.P. Is activity loss predictive for development of upper limb oedema after stroke? J. Rehabil. Med. 43 (5):398-403 (2011)
Gebruers N., Truijen S., Engelborghs S., De Deyn P.P. Incidence of upper limb oedema in patients with acute hemiparetic stroke. Disabil. Rehabil. 33 (19-20): 1791-1796 (2011)
Hermans E., Mariën P., De Deyn P.P. Sinus sigmoideus thrombosis secondary tot Graves´ disease: a case description. Case Rep. Neurol. 3: 203-209 (2011)
Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C.; Alzheimer's Disease Neuroimaging Initiative, van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S.; CHARGE consortium, Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alpérovitch A., Lathrop M.; EADI1 consortium, Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Björnsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43 (5): 429-35 (2011)
Mariën P., De Smet H.J., Wijgerde E., Verhoeven J., Crols R., De Deyn P.P. Posterior fossa syndrome in adults: A new case and comprehensive survey of the literature. Cortex. 2011 Jul 22; doi:10.1016/j.cortex.2011.06.018
Mariën P., Tops W., Crols R., Jonkers R., De Deyn P.P., Verhoeven J. Grammar disruption in a patient with Neuro-Sweet syndrome. Neurocase. 2011 Sep 1 ; DOI:10.1080/13554794.2011.588178 315. Meeus B., K. Nuytemans, D. Crosiers, S. Engelborghs, P. Pals, B. Pickut, K. Peeters, M. Mattheijssens, E. Corsmit, P. Cras, P.P. De Deyn, J. Theuns, C. Van Broeckhoven. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population. Neurobiol. Aging 32 (2): 308-312 (2011)
Rollinson S., J.D. Rohrer, J. van der Zee, K. Sleegers, S. Mead, S. Engelborghs, J. Collinge, P.P. De Deyn, D.M. Mann, C. Van Broeckhoven, S.M. Pickering-Brown. No association of PGRN 3´UTR rs5848 in frontotemporal lobar degeneration? Neurobiol. Aging 32 (4): 754-755 (2011)
Schallier A., Smolders I., Van Dam D., Loyens E., De Deyn P.P., Michotte A., Michotte Y., Massie A. Region- and Age-Specific Changes in Glutamate Transport in the A?PP23 Mouse Model for Alzheimer's Disease. J. Alzheimers Dis. 24 (2): 287-300 (2011)
Sheorajpanday R.V., Nagels G., Weeren A.J.T.M., De Deyn P.P. Quantitative EEG in ischemic stroke: Correlation with infarct volume and functional status in posterior circulation and lacunar syndromes. Clin. Neurophysiol. . 122 (5): 884-890 (2011)
Sheorajpanday R.V., Nagels G., Weeren A.J., van Putten M.J., De Deyn P.P. Quantitative EEG in ischemic stroke: Correlation with functional status after 6 months. Clin. Neurophysiol. 122 (5): 874-883 (2011)
Sprigg N., Gray L.J., Bath P.M., Christensen H., De Deyn P.P., Leys D., O'Neill D., Ringelstein E.B.; for the TAIST Investigators. Quality of Life after Ischemic Stroke Varies in Western Countries: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). J. Stroke Cerebrovasc. Dis. 2011 Mar 8; doi:10.1016/j.jstrokecerebrovasdis.2011.01.007
Van Dam D., De Deyn PP. Animal models in the drug discovery pipeline for Alzheimer's disease. Br. J. Pharmacol. 2011 Mar 3 ; doi:10.1111/j.1476-5381.2011.01299.x.
van der Zee J., Van Langenhove T., Kleinberger G., Sleegers K., Engelborghs S., Vandenberghe R., Santens P., Van den Broeck M., Joris G., Brys J., Mattheijssens M., Peeters K., Cras P., De Deyn P.P., Cruts M., Van Broeckhoven C. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 134 (Pt 3): 808-815 (2011)
Van Dijck A., Hayakawa E., Landuyt B., Baggerman G., Van Dam D., Luyten W., Schoofs L., De Deyn P.P. Comparison of extraction methods for peptidomics analysis of mouse brain tissue. J. Neurosci. Methods 197 (2): 231-237 (2011) 324. Van Ginneken C., Schäfer K.H., Van Dam D., Huygelen V., De Deyn P.P. Morphological changes in the enteric nervous system of aging and APP23 transgenic mice. Brain Res. 1378: 43-53 (2011)
Vermeiren Y., Le Bastard N., Clark C.M., Engelborghs S., De Deyn P.P. Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease. Neurochem. Res. 36 (10): 1858-1862 (2011)
Wostyn P., Audenaert K., De Deyn P.P. Alzheimer´s disease and glaucoma. (Author´s response) Brit. J. Ophtalmol. 95: 152-153 (2011)
Wostyn P., Van Dam D., Audenaert K., De Deyn P.P. Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease. Int. J. Alzheimers Dis. Volume 2011: Article ID 617420 (2011)
Wostyn P., Audenaert K., De Deyn P.P. Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease Therapy. Perspect. Medicin. Chem. 5: 11-17 (2011)
Wostyn P., De Groot V., Audenaert K., De Deyn P.P. Are intracranial pressure fluctuations important in glaucoma? Med. Hypotheses 77 (4): 598-600 (2011)
Lijst van publicaties IBB in 2010
Aries M.J.H., Le Bastard N., Debruyne H., Van Buggenhout M., Nagels G., De Deyn P.P., Engelborghs S. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. Int. J. Geriatr. Psychiatry 25 (11): 1186-1195 (2010)
Babiloni C., P.J. Visser, G. Frisoni, P.P. De Deyn, L. Bresciani, V. Jelic, G. Nagels, G. Rodriguez, P.M. Rossini, F. Vecchio, D. Colombo, F. Verhey, L.O. Wahlund, F. Nobili. Cortical sources of resting EEG rhytms in mild cognitive impairment and subjective memory complaint. Neurobiol. Aging 31 (10): 1787-1798 (2010)
Baillieux H., H.J. De Smet, A. Dobbeleir, P.F. Paquier, P.P. De Deyn, P. Mariën. Cognitive and affective disturbances following focal cerebellar damage in adults: A neuropsychological and SPECT study. Cortex 46 (7): 869-879 (2010)
Bettens K, Brouwers N., Van Miegroet H., Gil A., Engelborghs S., De Deyn P.P., Vandenberghe R., Van Broeckhoven C., Sleegers K.. Follow-Up Study of Susceptibility Loci for Alzheimer's Disease and Onset Age Identified by Genome-Wide Association. J. Alzheimers Dis. 19 (4): 1169-1175 (2010)
Brouns R., E. Heylen, J.L. Willemse, R. Sheorajpanday, D. De Surgeloose, R. Verkerk, P.P. De Deyn, D.F. Hendriks. The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome. J. Thromb. Haemost. 8 (1): 75-80 (2010)
Brouns R., Van Hemelrijck A., Drinkenburg W.H., Van Dam D., De Surgeloose D., De Deyn P.P. Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patients. Neurochem Int. 56 (8): 865-70 (2010)
Brouns R., Thijs V., Eyskens F., Van den Broeck M., Belachew S., Van Broeckhoven C., Redondo P., Hemelsoet D., Fumal A., Jeangette S., Verslegers W., Baker R., Hughes D., De Deyn P.P. BeFaS Investigators. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke 41 (5): 863-868 (2010)
Brouns R., B. De Vil, P. Cras, D. De Surgeloose, P. Mariën, P.P. De Deyn. Neurochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin. Chem. 56 (3): 451-458 (2010)
Brouns R., Wauters A., Van De Vijver G., De Surgeloose D., Sheorajpanday R., De Deyn P.P. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Clin. Chem. Lab. Med. 48 (3): 383-90 (2010)
Brouns R., Verkerk R., Aerts T., De Surgeloose D., Wauters A., Scharpé S., De Deyn P.P. The Role of Tryptophan Catabolism along the Kynurenine Pathway in Acute Ischemic Stroke. Neurochem. Res. 35 (9): 1315-1322 (2010)
Brouwers N., Bettens K., Gijselinck I., Engelborghs S., Pickut B.A., Van Miegroet H., Montoya A.G., Mattheijssens M., Peeters K., De Deyn P.P., Cruts M., Sleegers K., Van Broeckhoven C. Contribution of TARDBP to Alzheimer's Disease Genetic Etiology. J. Alzheimers Dis. 21 (2): 423-430 (2010)
Chen C.C., Engelborghs S., Dewaele S., Le Bastard N., Martin J.J., Vanhooren V., Libert C., De Deyn P.P. Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker? Rejuvenation Res. 13 (4): 439-444 (2010)
Deignan J.L., De Deyn P.P., Cederbaum S.D., Fuchshuber A., Roth B., Gsell W., Marescau B. Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia. Mol. Genet. Metab. 100 Suppl 1:S31-6 (2010)
De Meyer G., Shapiro F., Vanderstichele H., Vanmechelen E., Engelborghs S., De Deyn P.P., Coart E., Hansson O., Minthon L., Zetterberg H., Blennow K., Shaw L., Trojanowski J.Q.; for the Alzheimer's Disease Neuroimaging Initiative. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67 (8):949-956 (2010)
De Smet H.J., Paquier P.J., De Deyn P.P., Mariën P. The cerebellum and neurocognition: a review of clinical and neuroimaging studies. Am. J. Clin. Neurol. 2010 March 10; in press
England T.J., Bath P.M., Sare G.M., Geeganage C., Moulin T., O'Neill D., Woimant F., Christensen H., De Deyn P.P., Leys D., Ringelstein E.B.; on behalf of the TAIST Investigators. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype. Assessment from the Tinzaparin in acute ischaemic stroke trial. Stroke 41(12):2834-2839 (2010)
Gebruers N., Vanroy C., Truijen S., Engelborghs S., De Deyn P.P. Monitoring of physical activity after stroke: a systematic review of accelerometry-based measures. Arch. Phys. Med. Rehabil. 91 (2): 288-297 (2010)
Gijselinck I., Engelborghs S., Maes G., Cuijt I., Peeters K., Mattheijssens M., Joris G., Cras P., Martin J.J., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C., Cruts M. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch. Neurol. 67 (5): 606-616 (2010)
Gonsette R.E., Sindic C., D'hooghe M.B., De Deyn P.P., Medaer R., Michotte A., Seeldrayers P., Guillaume D.; ASIIMS study group. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing-remitting Multiple Sclerosis (ASIIMS) trial. Mult. Scler. 16 (4): 455-462 (2010)
Hudry E., D. Van Dam, W. Kulik, P.P. De Deyn, F.S. Stet, O. Ahouansou, A. Benraiss, A. Delacourte, P. Bougnères, P. Aubourg, N. Cartier. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer´s disease. Mol. Ther. 18 (1): 44-53 (2010)
Lambert J.C., Sleegers K., González-Pérez A., Ingelsson M., Beecham G.W., Hiltunen M., Combarros O., Bullido M.J., Brouwers N., Bettens K., Berr C., Pasquier F., Richard F., Dekosky S.T., Hannequin D., Haines J.L., Tognoni G., Fiévet N., Dartigues J.F., Tzourio C., Engelborghs S., Arosio B., Coto E., De Deyn P., Del Zompo M., Mateo I., Boada M., Antunez C., Lopez-Arrieta J., Epelbaum J., Schjeide B.M., Frank-Garcia A., Giedraitis V., Helisalmi S., Porcellini E., Pilotto A., Forti P., Ferri R., Delepine M., Zelenika D., Lathrop M., Scarpini E., Siciliano G., Solfrizzi V., Sorbi S., Spalletta G., Ravaglia G., Valdivieso F., Vepsäläinen S., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Hanon O., Piccardi P., Annoni G., Mann D., Marambaud P., Seripa D., Galimberti D., Tanzi R.E., Bertram L., Lendon C., Lannfelt L., Licastro F., Campion D., Pericak-Vance M.A., Soininen H., Van Broeckhoven C., Alpérovitch A., Ruiz A., Kamboh M.I., Amouyel P. The CALHM1 P86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer's Disease: a Meta-Analysis Study. J. Alzheimers Dis. 22 (1): 247-255 (2010)
Le Bastard N., Leurs J., Blomme W., De Deyn P.P., Engelborghs S. Plasma amyloid-b forms in Alzheimer´s disease and non-Alzheimer´s disease patients. J. Alzheimers Dis. 21 (1): 291-301 (2010)
Le Bastard N., J.-J.Martin, E. Vanmechelen, H. Vanderstichele, P.P. De Deyn., S. Engelborghs. Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiol. Aging 31 (11): 1867-1876 (2010)
Mariën P., Wackenier P., De Surgeloose D., De Deyn P.P., Verhoeven J. Developmental Coordination Disorder: Disruption of the Cerebello-Cerebral Network evidenced by SPECT. Cerebellum 9 (3): 405-410 (2010)
Meeus B., Nuytemans K., Crosiers D., Engelborghs S., Peeters K., Mattheijssens M., Elinck E., Corsmit E., De Deyn P.P., Van Broeckhoven C., Theuns J. Comprehensive Genetic and Mutation Analysis of Familial Dementia with Lewy Bodies Linked to 2q35-q36. J. Alzheimers Dis. 20 (1): 197-205 (2010)
Nguyen A.T., Aerts T., Van Dam D., De Deyn P.P. Biogenic amines and their metabolites in mouse brain tissue: Development, optimization and validation of an analytical HPLC method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878 (29): 3003-3014 (2010)
Serroyen J., G. Molenberghs, M. Aerts, E. Vloeberghs, P.P. De Deyn, G. Verbeke. Flexible estimation of serial correlation in nonlinear mixed models. J. Applied Statistics 37 (5): 833-846 (2010)
Sheorajpanday R.V., Nagels G., Weeren A.J., De Surgeloose D., De Deyn P.P. Additional value of quantitative EEG in acute anterior circulation syndrome of presumed ischemic origin. Clin. Neurophysiol. 121 (10): 1719-1725 (2010)
Urwin H., Josephs K.A., Rohrer J.D., Mackenzie I.R., Neumann M., Authier A., Seelaar H., Van Swieten J.C., Brown J.M., Johannsen P, Nielsen J.E., Holm I.E.; The FReJA Consortium, Dickson D.W., Rademakers R., Graff-Radford N.R., Parisi J.E., Petersen R.C., Hatanpaa K.J., White III C.L., Weiner M.F., Geser F., Van Deerlin V.M., Trojanowski J.Q., Miller B.L., Seeley W.W., van der Zee J., Kumar-Singh S., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Bigio E.H., Deng H.X., Halliday G.M., Kril J.J., Munoz D.G., Mann D.M., Pickering-Brown S.M., Doodeman V., Adamson G., Ghazi-Noori S., Fisher E.M., Holton J.L., Revesz T., Rossor M.N., Collinge J., Mead S., Isaacs A.M. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 120 (1): 33-41 (2010)
Vanacker P., Thijs V., Peeters A., Bruneel B., Laloux P., Druwé P., De Deyn P., Ahmed N., Wahlgren N., Vanhooren G. for the Belgian SITS-collaboration group. The Belgian experience with intravenous thrombolysis for acute ischemic stroke. Acta Neurol. Belg. 110: 157-162 (2010)
Vanacker P., Thijs V., Peeters A., Bruneel B., Laloux P., Druwé P., De Deyn P., Ahmed N., Wahlgren N., Vanhooren G. for the Belgian SITS-collaboration group. The Belgian experience with intravenous thrombolysis for acute ischemic stroke. Acta Neurol. Belg. 110 (2):157-162 (2010)
Van Dam D., K. Coen, P. De Deyn. Ibuprofen modifies cognitive disease progression in an Alzheimer´s mouse model. J. Psychopharmacol. 24 (3): 383-388 (2010)
Vanhooren V., Dewaele S., Libert C., Engelborghs S., De Deyn P.P., Toussaint O., Debacq-Chainiaux F., Poulain M., Glupczynski Y., Franceschi C., Jaspers K., der Pluijm I.V., Hoeijmakers J., Chen C.C. Serum N-Glycan Profile Shift During Human Ageing. Exp. Gerontol. 45 (10): 738-743 (2010)
van Laar T., De Deyn P.P., Aarsland D., Barone P., Galvin J.E. Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data. CNS Neurosci. Ther. 2010 Jul 7
Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M., Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74 (5): 366-71 (2010)
Wostyn P., Audenaert K., De Deyn P.P. High occurrence rate of glaucoma among patients with normal pressure hydrocephalus. J. Glaucoma 19 (3): 225-226 (2010)
Wostyn P., Audenaert K., De Deyn P.P. Alzheimer's disease: Cerebral glaucoma? Med. Hypotheses 74 (6): 973-977 (2010)
Lijst van publicaties IBB in 2009
Azdad K., M. Chavez, P. Don Bischop, P. Wetzelaer, B. Marescau, P.P. De Deyn, D. Gall, S.N. Schiffmann. Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion. PloS One 4 (9): e6908 (2009)
Baillieux H., E.J. Vandervliet, M. Manto, P.M Parizel, P.P. De Deyn, P. Mariën. Developmental dyslexia and widespread activation across the cerebellar hemispheres. Brain Lang. 108 (2): 122-132 (2009)
Bettens K., N. Brouwers, S. Engelborghs, T. De Pooter, P.P. De Deyn, K. Sleegers, C. Van Broeckhoven. DNMBP is genetically associated with Alzheimer dementia in the Belgian population. Neurobiol. Aging 30 (12): 2000-2009 (2009)
Bettens K., N. Brouwers, S. Engelborghs, H. Van Miegroet, P.P. De Deyn, J. Theuns, K. Sleegers, C. Van Broeckhoven. APP and BACE1 miRNA genetic variability has nog major role in risk for Alzheimer disease. Hum. Mut. 30 (8): 1207-13 (2009)
Brouns R., E. Heylen, R. Sheorajpanday, J.L. Willemse, J. Kunnen, D. Surgeloose, D.F. Hendriks, P.P. De Deyn. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients. Clin. Neurol. Neurosurg. 111 (2): 165-170 (2009)
Brouns R., B. Marescau, I. Possemiers, R. Sheorajpanday, P.P. De Deyn. Dimethylargininge levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem. Res. 34 (9): 1642-49 (2009)
Brouns R., R. Sheorajpanday, J. Kunnen, D. Surgeloose, P.P. De Deyn. Clinical, biochemical and neuroimaging parameters after trombolytic therapy predict long-term stroke outcome. Eur. Neurol. 62 (1): 9-15 (2009)
Brouns R., P.P. De Deyn. The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111 (6): 483-495 (2009)
Brouns R., J. Van den Bossche, D. Surgeloose, R. Sheorajpanday, P.P. De Deyn. Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke. J. Neurol. Sci. 285 (1-2): 185-190 (2009)
Brouns R. F. Eyskens, K. De Boeck, C. Ceuterick-de Groote, M. Van den Broeck, C. Van Broeckhoven, P. P. De Deyn. Fabry disease in a patient with Turner syndrome. J. Inherit. Metab. Dis. 2009 Apr 5; doi 10.1007/s10545-009-1035-x
Debruyne H., M. Van Buggenhout, N. Le Bastard, M. Aries, K. Audenaert, P.P. De Deyn, S. Engelborghs. Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment? Int. J. Geriatr. Psychiatry 24: 556-562 (2009)
De Deyn P.P., R. Vanholder, S. Eloot, G. Glorieux. Guanidino compounds as uremic (neuro)toxins. Semin. Dial. 22 (4): 340-345 (2009)
De Rijck A., R. Brouns, M. Geurden, M. Elseviers, P.P. De Deyn, S. Engelborghs. Risicofactoren voor depressie na een cerebrovasculair accident – Een systematische literatuurstudie. Tijdschr. voor Geneeskunde 65 (7): 282-290 (2009)
De Smet H.J., H. Baillieux, P. Wackenier, M. De Praeter, S. Engelborghs, P.F. Paquier, P.P. De Deyn, P. Mariën. Long-term cognitive deficits following posterior fossa tumor resection: A neuropsychological and functional neuroimaging follow-up study. Neuropsychology 23 (6): 694-704 (2009)
D´Hulst C., I. Heulens, J.R. Brouwer, R. Willemsen, N. De Geest, S.P. Reeve, P.P. De Deyn, B.A. Hassan, R.F. Kooy. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/attaxia syndrome (FXTAS). Brain Res. 1253: 176-183 (2009)
Dierckx E., S. Engelborghs, R. De Raedt, M. Van Buggenhout, P.P. De Deyn, D. Verté, I. Ponjaert-Kristoffersen. Verbal cued recal as a predictor of conversion to Alzheimer´s disease in Mild Cognitive Impairment. Int. J. Geriatr. Psychiatry 24 (10): 1094-1100 (2009)
Eloot S., W. van Biesen, A. Dhondt, R. de Smet, B. Marescau, P.P. De Deyn, P. Verdonck, R. Vanholder. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol. Dial. Transplant. 24 (7): 2225-32 (2009)
Gijselinck I., K. Sleegers, S. Engelborghs, W. Robberecht, J.J. Martin, R. Vandenberghe, R. Sciot, B. Dermaut, D. Goossens, J. van der Zee, T. De Pooter, J. Del-Favero, P. Santens, P. De Jonghe, P.P. De Deyn, C. Van Broeckhoven, M. Cruts. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol. Aging 30: 1329-1331 (2009)
Koopman K., N. Le Bastard, J.-J. Martin, G. Nagels, P.P. De Deyn, S. Engelborghs. Improved discrimination of autopsy-confirmed Alzheimer´s disease (AD) from non-AD dementias using CSF P-tau181P. Neurochem. Int. 55 (4): 214-218 (2009)
Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O.; European Alzheimer's Disease Initiative Investigators, de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer´s disease. Nat. Genet. 41 (10): 1088-1093 (2009)
Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O.; European Alzheimer's Disease Initiative Investigators, de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41(10):1094-1099 (2009)
Le Bastard N., L. Aerts, J. Leurs, W. Blomme, P.P. De Deyn, S. Engelborghs. No correlation between time-linked plasma and CSF A? levels. Neurochem. Int. 55 (8): 820-825 (2009)
Le Bastard N., P.P. De Deyn, S. Engelborghs. Cerebrospinal fluid biomarkers for the differential diagnosis of dementia. CML — Neurology 25 (3): 59-68 (2009)
Mariën P., H. Bailleux, H.J. De Smet, S. Engelborghs, I. Wilssens, P. Paquier, P.P. De Deyn. Cognitive, linguistic and affective disturbances following a right superior cerebellar artery infarction: a case study. Cortex 45 (4): 527-536 (2009)
Mariën P., J. Verhoeven, P. Wackenier, S. Engelborghs, P.P. De Deyn. Foreign accent syndrome as a developmental motor speech disorder. Cortex 45 (7): 870-878 (2009)
Nuytemans K., B. Meeus, D. Crosiers, N. Brouwers, D. Goossens, S. Engelborghs, P. Pals, B. Pickut, M. Van den Broeck, E. Corsmit, P. Cras, P.P. De Deyn, J. Del-Favero, C Van Broeckhoven, J. Theuns. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum. Mutat. 30 (7): 1054-61 (2009)
Sare G.M., P.M. Bath, L.J. Gray, T. Moulin, R. Woimant, T. England, C. Geeganage, H. Christensen, P.P. De Deyn, D. Leys, D. O´Neill, E.B. Ringelstein; TAIST Investigators. The relationship between baseline blood pressure and computed tomography finding in acute stroke: data from the tinzaparin in acute ischaemic stroke trial. Stroke 40 (1): 41-46 (2009)
Sheorajpanday R.V., G. Nagels, A.J. Weeren, M.J. van Putten, P.P. De Deyn. Reproducibility and clinical relevance of quantitative EEG parameters in cerebral ischemia: A basic approach. Clin. Neurophysiol. 120 (5): 845-55 (2009)
Sleegers K., K. Bettens, N. Brouwers, S. Engelborghs, H. van Miegroet, P.P. De Deyn, C. Van Broeckhoven. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Hum. Mutat. 30 (2): E338-E344 (2009)
Sleegers K., N. Brouwers, K. Bettens, S. Engelborghs, H. van Miegroet, P.P. De Deyn, C. Van Broeckhoven. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum. Mutat. 30 (4): E570-574 (2009)
Sleegers K., N. Brouwers, P. Van Damme, S. Engelborghs, I. Gijselinck, J. van der Zee, K. Peeters, M. Mattheijssens, M. Cruts, R. Vandenberghe, P.P. De Deyn, W. Robberecht, C. Van Broeckhoven. Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann. Neurol. 65 (5): 603-9 (2009)
Szot P. D. Van Dam, S.S. White, A. Franklin, M. Staufenbiel, P.P. De Deyn. Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice. Neurosci. Lett. 463 (1): 93-97 (2009)
Thijs V., Peeters A., Dewindt A., Hemelsoet D., De Klippel N., Laloux P., Redondo P., Cras P., De Deyn P.P., Desfontaines P., Brouns R., De Raedt S., Van Landegem W., Vandermeeren Y., Vanhooren G. Organisation of inhospital acute stroke care and minimum criteria for stroke care units. Recommendations of the Belgian Stroke Council. Acta Neurol Belg. 109 (4): 247-51 (2009)
van der Zee J., D. Pirici, T. Van Langenhove, S. Engelborghs, R. Vandenberghe, M. Hoffmann, G. Pusswald, M. Van den Broeck, K. Peeters, M. Mattheijssens, J.-J. Martin, P.P. De Deyn, M. Cruts, D. Haubenberger, S. Kumar-Singh, A. Zimprich, C. Van Broeckhoven. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 73 (8): 626-632 (2009)
Van Dijck A., D. Van Dam, V. Vergote, B. De Spiegeleer, W. Luyten, L. Schoofs, P.P. De Deyn. Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. Regulatory Peptides 156 (1-3): 77-82 (2009)
Van Dijck A., D. Van Dam, P.P. De Deyn. NAP has no effect on spatial memory after short-term treatment in advanced stage Alzheimer´s disease mouse model. Peptides 30: 2480-2482 (2009)
Vanholder R., O. Abou-Deif, A. Argiles, U. Baurmeister, J. Beige, P. Brouckaert, P. Brunet, G. Cohen, P.P. De Deyn, T.B. Drüeke, D. Fliser D, G. Glorieux, S. Herget-Rosenthal, W.H. Hörl, J. Jankowski, A. Jörres, Z.A. Massy, H. Mischak, A.F. Perna, J.M. Rodriguez-Portillo, G. Spasovski, B.G. Stegmayr, P. Stenvinkel, P.J. Thornalley, C. Wanner, A. Wiecek. The role of EUTox in uremic toxin research. Semin. Dial. 22 (4): 323-328 (2009)
Verwey N.A., W.M. van der Flier, K. Blennow, C. Clark, S. Sokolow, P.P. De Deyn, D. Galasko, H. Hampel, T. Hartmann, E. Kapaki, L. Lannfelt, P.D. Mehta, L. Parnetti, A. Petzold, T. Pirttila, L. Saleh, A. Skinningsrud, J.C. v. Swieten, M.M. Verbeek, J. Wiltfang, S. Younkin, P. Scheltens and M.A. Blankenstein. A wordlwide multicenter comparison of assays for cerebrospinal fluid biomarkers in Alzheimer´s disease. Ann. Clin. Biochem. 46 (Pt 3): 235-240 (2009)
Wostyn P., K. Audenaert, P.P. De Deyn. The Valsavo maneuver and Alzheimer´s disease: is there a link? Curr. Alzheimer Res. 6 (1): 59-68 (2009)
Wostyn P., K. Audenaert, P.P. De Deyn. More advanced Alzheimer´s disease may be associated with a decrease in cerebrospinal fluid pressure. Cerebrospinal Fluid Res. 6 (1): 14 (2009) Open Acces http://www.cerebrospinalfluidresearch.com/content/6/1/14
Wostyn P., K. Audenaert, P.P. De Deyn. Alzheimer´s disease and glaucoma: Is there a causal relationship? Br. J. Ophtalmol. 93 (12): 1557-1559 (2009)
Lijst van publicaties IBB in 2008
Aalten P., F.R. Verhey, M. Boziki, A. Brugnolo, R. Bullock, E.J. Byrne, V. Camus, M. Caputo, D. Collins, P.P. De Deyn, K. Elina, G. Frisoni, C. Holmes, C. Hurt, A. Marriott, P. Mecocci, F. Nobili, P.J. Ousset, E. Reynish, E. Salmon, M. Tsolaki, B. Vellas, P.H. Robert. Consistency of neuropsychiatric syndromes across dementias: Results from the European Alzheimer Disease Consortium. Part II. Dement. Geriatr. Cogn. Disord. 25 (1): 1-8 (2008)
Aries M.J., Debruyne H., Engelborghs S., Le Bastard N., Somers N., Gorissen D., Pickut B.A., De Deyn P.P. Reversal of head drop after discontinuation of olanzapine in a DLB patient. Mov. Disord. 23 (12): 1760-1762 (2008)
Bailleux H., W. Verslegers, P. Paquier, P.P. De Deyn, P. Mariën. Cerebellar cognitive affective syndrome associated with topiramate. Clin. Neurol. Neurosurg. 110 (5): 496-499 (2008)
Bailleux H., De Smet H.J., Paquier P.F., De Deyn P.P., Mariën P. Cerebellar neurocognition: Insights into the bottom of the brain. Clin. Neurol. Neurosurg. 110 (8): 763-73 (2008)
Bettens K., N. Brouwers, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, K. Sleegers. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum. Mutat. 29 (5): 769-770 (2008)
Bogaerts V., K. Nuytemans, J. Reumers, P. Pals, S. Engelborghs, B. Pickut, E. Corsmit, K. Peeters, J. Schymkowitz, P.P. De Deyn, P. Cras, F. Rousseau, J. Theuns, C. Van Broeckhoven. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum. Mutat. 29 (6): 832-840 (2008)
Brouns R., Sheorajpanday R., Wauters A., De Surgeloose D., Mariën P., De Deyn P.P. Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clin. Chim Acta. 397 (1-2): 27-31 (2008)
Brouwers N., Sleegers K, Engelborghs S., Maurer-Stroh S., Gijselinck I., van der Zee J., Pickut B.A., Van den Broeck, Mattheijssens M., Peeters K., Schymkowitz J., Rousseau F., Martin J.-J., Cruts M., De Deyn P.P., Van Broeckhoven C. Genetic variability in progranulin contributes to risk for clinical diagnosed Alzheimer disease. Neurology 71: 656-664 (2008)
Deignan J.L., B. Marescau, J.C. Livesay, R.K. Iyer, P.P. De Deyn, S.D. Cederbaum, W.W. Grody. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Mol. Genet. Metab. 93: 172-178 (2008)
De Witte L., Engelborghs S., Verhoeven J., De Deyn P.P., Mariën P. Disrupted auto-activation, dysexecutive and confabulating syndrome following bilateral thalamic and right putaminal stroke. Behav. Neurol. 19 (3):145-51 (2008)
De Witte L., J. Verhoeven, S. Engelborghs, P.P. De Deyn, P. Mariën. Crossed aphasia and visuo-spatial neglect following a right thalamic stroke: a case study and review of the literature. Behav. Neurol. 19 (4): 177-194 (2008)
Dierckx E., S. Engelborghs, R. De Raedt, M. Van Buggenhout, P.P. De Deyn, G. Verleye, D. Verte, I. Ponjaert-Kristoffersen. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? J. Geriatr. Psychiatry Neurol. 21 (4): 242-249 (2008)
Engelborghs S., E. Vloeberghs, N. Le Bastard, M. Van Buggenhout, P. Mariën, N. Somers, G. Nagels, B.A. Pickut, P.P. De Deyn. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem. Int. 52 (6): 1052-1060 (2008)
Engelborghs S., K. De Vreese, T. Van de Casteele, H. Vanderstichele, B. Van Everbroeck, P. Cras, J.-J. Martin, E. Vanmechelen, P.P. De Deyn. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 29 (8):1143-59 (2008)
Errijgers V., E. Fransen, R. D´Hooge, P.P. De Deyn, R.F. Kooy. Effect of genetic background on acoustic startle response in fragile X knockout mice. Genet. Res. 90 (4): 341-345 (2008)
Gebruers N., S. Truijen, S. Engelborghs, G. Nagels, R. Brouns, P.P. De Deyn. Actigraphic measurement of motor deficits in acute ischemic stroke. Cerebrovasc. Dis. 26 (5): 533-540 (2008)
Gijselinck I., J. van der Zee, S. Engelborghs, D. Goossens, K. Peeters, M. Mattheijssens, E. Corsmit, J. Del-Favero, P.P. De Deyn, C. Van Broeckhoven, M. Cruts. Progranulin locus deletion in frontotemporal dementia. Hum. Mutat. 29 (1): 53-58 (2008)
Haugarvoll K., R. Rademakers, J.M. Kachergus, K. Nuytemans, O.A. Ross, J.M Gibson, E.K. Tan, C. Gaig, E. Tolosa, S. Goldwurm, M. Guidi, G. Riboldazzi, L. Brown, U. Walter, R. Benecke, D. Berg, T. Gasser, J. Theuns, P. Pals, P. Cras, P.P. De Deyn, S. Engelborghs, B. Pickut, R.J. Uitti, T. Foroud, W.C. Nichols, J. Hagenah, C. Klein, A. Samii, C.P. Zabetian, V. Bonifati, C. Van Broeckhoven, M.J. Farrer, Z.K. Wszolek. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70 (16): 1456-1460 (2008)
Hulshagen L., O. Krysko, A. Bottelbergs, S. Huyghe, R. Klein, P.P. Van Veldhoven, P.P. De Deyn, R. D´Hooge, D. Hartman, M. Baes. Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. J. Neurosci. 28 (15): 4015-4027 (2008)
Levillain O., B. Marescau, I. Possemiers, P.P. De Deyn. Accumulation of methylguanidine and changes in guanidino compounds levels in plasma, urine, and kidneys of furosemide-treated rats. Metabolism 57 (6): 802-810 (2008)
Mariën P., R. Brouns, S. Engelborghs, P. Wackenier, J. Verhoeven, B. Ceulemans, P.P. De Deyn. Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome. Cortex 44 (1): 54-67 (2008)
Nagels G., M.B. D´hooghe, D. Kos, S. Engelborghs, P.P. De Deyn. Within-session practice effect on paced auditory serial addition test in multiple sclerosis. Multiple Sclerosis 14: 106-111 (2008)
Nuytemans K., R. Rademakers, J. Theuns, P. Pals, S. Engelborghs, B. Pickut, T. de Pooter, K. Peeters, M. Mattheijssens, M. Van den Broeck, P. Cras, P.P. De Deyn, C. Van Broeckhoven. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson´s disease patients. Eur. J. Hum. Genet. 16 (4): 471-479 (2008)
Nuytemans K., P. Pals, K. Sleegers, S. Engelborghs, E. Corsmit, K. Peeters, B. Pickut, M. Mattheijssens, P. Cras, P.P. De Deyn, J. Theuns, C. Van Broeckhoven. Progranulin variability has no major role in Parkinson disease genetic etiology. Neurology 71(15):1147-51 (2008)
Oertel W., W. Poewe, E. Wolters, P.P. De Deyn, M. Emre, C. Kirsch, C. Hsu, S. Tekin, R. Lane. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson´s disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug Saf. 31 (1): 79-94 (2008)
Taes Y.E.C., B. Marescau, A. De Vriese, P.P. De Deyn, E. Schepers, R. Vanholder, J.R. Delanghe. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol. Dial. Transplant. 23 (4): 1330-1335 (2008)
Van Broeck B., G. Vanhoutte, D. Pirici, D. Van Dam, H. Wils, I. Cuijt, K. Vennekens, M. Zabielski, A. Michalik, J. Theuns, P.P. De Deyn, A. Van der Linden, C. Van Broeckhoven, S. Kumar-Singh. Intraneuronal amyloid ? and reduced brain volume in a novel APPT7141 mouse model for Alzheimer´s disease. Neurobiol. Aging 29: 241-252 (2008)
Van Dam D., K. Coen, P.P. De Deyn. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer´s disease. Psychopharmacology 197 (1): 37-43 (2008)
Vandervliet E.J.M., J. Verhoeven, S. Engelborghs, P.P. De Deyn, P.M. Parizel, P. Mariën. fMRI findings in an aphasic patient with reversed cerebral dominance for language. Acta Neurol. Belg. 108: 161-166 (2008)
van der Zee J., H. Urwin, S. Engelborghs, M. Bruyland, R. Vandenberghe, B. Dermaut, T. De Pooter, K. Peeters, P. Santens, P.P. De Deyn, E.M. Fisher, J. Collinge, A.M. Isaacs, C. Van Broeckhoven. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associate with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 17 (2): 313-322 (2008)
Van Dijck A., E. Vloeberghs, D. Van Dam, M. Staufenbiel, P.P. De Deyn. Evaluation of the APP23-model for Alzheimer´s disease in the odour paired-associate test for hippocampus-dependent memory. Behav. Brain Res. 190 (1): 147-151 (2008)
Vanholder R., P.P. De Deyn, W. Van Biesen, N. Lameire. Marconi revisited: From kidney to brain – Two organ systems communicating at long distance. J. Am. Soc. Nephrol. 19 (7): 1253-1255 (2008)
Verslegers W.R., F. Van Thielen, P.P. De Deyn. Effectiviteit van endarteriëctomie voor symptomatische stenose van de A. carotis; meer factoren belangrijk dan alleen de ernst van de stenose. (Letter) Ned. Tijdschr. Geneeskd. 152 (14): 843-844 (2008)
Verslegers W.R., P.P. De Deyn. De standaard ”stoppen met roken” van het Nederlands Huisartsen Genootschap. (Letter) Ned. Tijdschr. Geneeskd. 152 (37): 2043 (2008)
Visser P.J., F.R. Verhey, M. Boada, R. Bullock, P.P. De Deyn, G.B. Frisoni, L. Frolich, H. Hampel, J. Jolles, R. Jones, L. Minthon, F. Nobili, M. Olde Rikkert, P.J. Ousset, A.S. Rigaud, P. Scheltens, H. Soininen, L. Spiru, J. Touchon, M. Tsolaki, B. Vellas, L.O. Wahlund, G. Wilcock, B. Winblad; DESCRIPA study group. Development of screening guidelines and clinical criteria for predementia Alzheimer´s disease. The DESCRIPA Study. Neuroepidemiology 30 (4): 254-265 (2008)
Vloeberghs E., D. Van Dam, F. Franck, J. Serroyen, G. Molenberghs, M. Staufenbiel, P.P. De Deyn. Altered ingestive behavior, weight changes and intact olfactory sense in an APP overexpression model. Behav. Neurosci. 122 (3): 491-497 (2008)
Vloeberghs E., K. Coen, D. Van Dam, P.P. De Deyn. Validation of the APP23 model of Alzheimer´s disease through evaluation of risperidone treatment on aggressive behaviour. Arzneimittel – Forschung/Drug Res. 58 (6): 265-268 (2008)
Willemse J.L., R. Brouns, E. Heylen, P.P. De Deyn, D.F. Hendriks. Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy. J. Thromb. Haemost. 6 (1): 200-202 (2008)
Wostyn P., K. Audenaert, P.P. De Deyn. Alzheimer´s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin. Neurol. Neurosurg. 110 (2): 101-109 (2008)
Wostyn P., Audenaert K., De Deyn P.P. An abnormal high trans-lamina cribrosa pressure difference: a missing link between Alzheimer´s disease and glaucoma? Clin. Neurol. Neurosurg. 110 (7): 753-754 (2008)
Lijst van publicaties IBB in 2007
Aalten P., F.R. Verhey, M. Boziki, R. Bullock, E.J. Byrne, V. Camus, M. Caputo, D. Collins, P.P. De Deyn, K. Elina, G. Frisoni, N. Girtler, C. Holmes, C. Hurt, A. Marriott, P. Mecocci, F. Nobili, P.J. Ousset, E. Reynish, E. Salmon, M. Tsolaki, B. Vellas, P.H. Robert. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consorium: Part I. Dement. Geriatr. Cogn. Disord. 24 (6): 457-463 (2007). (IF = 2.511)
Aarsland D., K. Bronninck, U. Ehrt, P.P. De Deyn, S. Tekin, M. Emre, J.L. Cummings. Neuropsychiatric symptoms in patients with PD and dementia: Frequency, profile and associated caregiver stress. J. Neurol. Neurosurg. Psychiatry 78 (1): 36-42 (2007)
Auchus A.P., H.R. Brashear, S. Salloway, A.D. Korczyn, P.P. De Deyn, for the GAL-INT-26 Study Group. Galantamine treatment of vascular dementia: a randomized trial. Neurology 69 (5): 448-458 (2007)
Abrahantes J.C., Aerts M., van Everbroeck B., Saegerman C., Berkvens D., Geys H., Mintiens K., Roels S., Cras P., Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics. Eur. J. Epidemiol. 22 (7): 457-65 (2007). (IF = 1.605)
Baar I., Jacobs B.C., Govers N., Jorens P.G., Parizel P.M., Cras P., Campylobacter jejuni-induced acute transverse myelitis. Spinal Cord. 45 (10): 690-4 (2007). (IF = 1.791)
Baillieux H., F. Weyns, P. Paquier, P.P. De Deyn, P. Mariën. Posterior fossa syndrome after a vermian stroke: a new case of the literature. Pediatr. Neurosurg. 43 (5): 386-395 (2007). (IF = 0.972)
Bogaerts V., S. Engelborghs, S. Kumar-Singh, D. Goossens, B. Pickut, J. van der Zee, K. Sleegers, K. Peeters, J.-J. Martin, J. Del-Favero, T. Gasser, D.W. Dickson, Z.K. Wszolek, P.P. De Deyn, J. Theuns, C. Van Broeckhoven. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 130: 2277-2291 (2007). (IF = 7.617)
Bogaerts, V., Theuns, J., Van Broeckhoven, C. Genetic findings in Parkinson's disease and their translation towards treatment: a leading part for mitochondria? Genes Brain and Behavior (2007)(Epub ahead) (IF = 4.385)
Brouns R., R. Sheorajpanday, E. Braxel, F. Eyskens, R. Baker, D. Hughes, A. Mehta, T. Timmerman, M.-F. Vincent, P.P. De Deyn. Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patiens with cryptogenic stroke. Clin. Neurol. Neurosurg. 109: 479-484 (2007). (IF = 1.506)
Brouwers N., K. Nuytemans, J. van der Zee, I. Gijselinck, S. Engelborghs, J. Theuns, S. Kumar-Singh, B.A. Pickut, P. Pals, B. Dermaut, V. Bogaerts, T. De Pooter, S. Serneels, M. Van den Broeck, I. Cuijt, M. Mattheijssens, K. Peeters, R. Sciot, J.J. Martin, P. Cras, P. Santens, R. Vandenberghe, P.P. De Deyn, M. Cruts, C. Van Broeckhoven, K. Sleegers. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch. Neurol. 64 (10): 1436-1446 (2007). (IF = 5.204)
Cannon R.C., Gewaltig M.O., Gleeson P., Bhalla U.S., Cornelis H., Hines M.L., Howell F.W., Muller E., Stiles J.R., Wils S., De Schutter E., Interoperability of neuroscience modeling software: current status and future directions. (Review) Neuroinformatics 5 (2): 127-38 (2007). (IF = 3.541)
Cohen G., G. Glorieux, P. Thornalley, E. Schepers, N. Meert, J. Jankowski, V. Jankowski, A. Argiles, B. Anderstam, P. Brunet, C. Cerini, L. Dou, R. Deppisch, B. Marescau, Z. Massy, A. Perna, J. Raupachova, M. Rodriguez, B. Stegmayr, R. Vanholder, W.H. Hörl for the European Uremic Toxin Work Group (EUTox). Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia. Nephrol. Dial. Transplant. 22: 3381-3390 (2007). (IF = 3.154)
Cornelis H., De Schutter E., Neurospaces: towards automated model partitioning for parallel computers. Neurocomputing: an international journal 70 (10/12): 2117-2121 (2007). (IF = 0.860)
De Bleecker JL, Paepe BD, Vervaet VL, Arys B, Creus KK, Werbrouck BF, Martin JJ. (2007) Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies. Neuromuscular Disorders 17:186-193. (IF = 2.615)
De Schutter E., Neuroscience leading the way: reviews cascade by the INCF. Neuroinformatics 5 (4): 205-6 (2007) (IF = 3.541)
De Smet H.J., H. Baillieux, C. Catsman-Berrevoets, P.P. De Deyn, P. Mariën, P.F. Paquier. Postoperative motor speech production in children with the syndrome of ´cerebellar´ mutism and subsequent dysarthria: A critiacal review of literature. Eur. J. Paediatr. Neurol. 11: 193-207 (2007 ). (IF = 1.364)
De Smet H.J., H. Baillieux, P.P. De Deyn, P. Mariën, P. Paquier. The cerebellum and language: The story so far. Folia Phoniatr. Logop. 59: 165-170 (2007). (IF = 0.655)
Dierckx E., Engelborghs S., De Raedt R., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? Journal of Geriatric Psychiatry and Neurology. In druk (IF = 1.970)
Dierckx E., S. Engelborghs, R. De Raedt, P.P. De Deyn, I. Ponjaert-Kristoffersen. Mild cognitive impairment: What´s in a name? Gerontology 53: 28-35 (2007). (IF = 1.439)
Dierckx E., S. Engelborghs, R. De Raedt, P.P. De Deyn, I. Ponjaert-Kristoffersen. Differentiation between mild cognitive impairment, Alzheimer´s disease and depression by means of cued recall. Psychol. Med. 37 (5): 747-55 (2007). (IF = 3.816)
Dierick, I., Irobi, J., Janssens, S., Theuns, J., Lemmens, R., Jacobs, A., Corsmit, E., Hersmus, N., Van Den Bosch, L., Robberecht, W., De Jonghe, P., Van Broeckhoven, C., Timmerman, V. (2007) Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Human Mutation, 28: 830 (IF = 6.473)
Ehrt U., K. Broninck, P.P. De Deyn, M. Emre, S. Tekin, R. Lane, D. Aarsland. Subtreshold depression in patients with Parkinson´s disease and dementia - clinical and demographic correlates. Int. J. Geriatr. Psychiatry 22: 980-983 (2007). (IF = 1.930)
Eloot S., A. Torremans, R. De Smet, B. Marescau, P.P. De Deyn, P. Verdonck, R. Vanholder. Complex compartmental behavior of small water-soluble uremic retention solutes: Evaluation by direct measurements in plasma and erythrocytes. Am. J. Kidney Dis. 50 (2): 279-288 (2007). (IF = 4.072)
Engelborghs S., K. De Vreese, T. Van de Casteele, H. Vanderstichele, B. Van Everbroeck, P. Cras, J.-J. Martin, E. Vanmechelen, P.P. De Deyn. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 2007, Apr 9; (Epub ahead of print). (IF = 5.599)
Engelborghs S., K. Sleegers, P. Cras, N. Brouwers, S. Serneels, E. De Leenheir, J.J. Martin, E. Vanmechelen, C. Van Broeckhoven, P.P. De Deyn. No association of CSF biomarkers with APOE (varepsilon) 4, plaque and tangle burden in definite Alzheimer´s disease. Brain 130: 2320-2326 (2007). (IF = 7.617)
Engelborghs S., Vloeberghs E., Le Bastard N., Van Buggenhout M., Mariën P., Somers N., Nagels G., Pickut B.A., De Deyn P.P. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochemistry International. Epub nov 2007. (IF = 3.159)
Errijgers V., D. Van Dam, I. Gantois, C.J. Van Ginneken, A.W. Grossman, R. D´Hooge, P.P. De Deyn, , R.F. Kooy. FVBS/.129P2-Pde6b(+) Tyr (c-ch)/Ant, a sighted variant of the FVB/N strain suitable for behavioral analysis. Genes Brain Behav. 6 (6): 552-557 (2007). (IF = 4.385)
Gebruers N., S. Truijen, S. Engelborghs, P.P. De Deyn. Volumetric evaluation of upper extremities in 250 healthy persons. Clin. Physiol. Funct. Imaging 27: 17-22 (2007). (IF = 0.938)
Gijselinck, I., Sleegers, K., Engelborghs, S., Robberecht,W., Martin, J-J., Vandenberghe, R., Sciot,R., Dermaut, B., Goossens, D., van der Zee, J., De Pooter, T., Del-Favero, J., Santens, P., De Jonghe, P., De Deyn, P., Van Broeckhoven, C., Cruts, M.: Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiology of Aging Dec 2007). (IF = 5.599)
Gray L.J., N. Sprigg, P. Bath, G. Boysen, P.P. De Deyn, D. Leys, D. O´Neill, E. B. Ringelstein, for the TAIST Investigators. Sex differences in quality of life in stroke survivors: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 38 (11): 2960-2964 (2007)
Hakonen, A.H., Davidzon, G., Salemi, R., Bindoff, L.A., Van Goethem, G., Dimauro, S., Thorburn, D.R, Suomalainen, A. (2007) Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. European Journal of Human Genetics, 15: 779-783 (IF = 3.697)
Hauser R.A., O. Rascol, A. Dkorczyn, A. Jon Stoessl, R. L. Watts, W. Poewe, P.P. De Deyn. Ten-year follow-up of Parkinson´s disease patients randomized to initial therapy with ropinirole or levodopa. Mov. Disord. 22 (16): 2409-2417 (2007). (IF = 3.323)
Ivanova, N., Claeys, K., Deconinck, T, Litvinenko, I., Jordanova, A., Auer-Grumbach, M., Haberlova, J., Löfgren, A., Smeyers, G., Nelis, E., Mercelis, R., Plecko, B., Priller, J., Zámecník, J., Ceulemans, B., Erichsen, K., Björck, E., Nicholson, G., Sereda, M., Seeman, P., Kremensky, I., Mitev, V., De Jonghe, P. (2007) Hereditary spastic paraplegia 3A associated with axonal neuropathy. Archives of Neurology, 64: 706-713 (IF = 5.204)
Katz I., P.P. De Deyn, J. Mintzer, A. Greenspan, Y. Zhu, H. Brodaty. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer´s disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int. J. Geriatr. Psychiatry 22: 475-484 (2007). (IF = 1.930)
Kumar-Singh, S., Van Broeckhoven, C. (2007) Frontotemporal lobar degeneration: Current concepts and advances. Brain Pathology, 17: 104-113 (IF = 5.274)
Le Bastard N., M. Van Buggenhout, E. De Leenheir, J.-J. Martin, P.P. De Deyn, S. Engelborghs. Low specificity limits the use of the cerebrospinal fluid A?1-42/P-tau181P ratio to discriminate Alzheimer´s disease from vascular dementia. J. Gerontol. A Biol. Sci. Med. Sci. 62 (8): 923-924 (2007). (IF = 2.861)
Lehtokari V-L, Ceuterick-de Groote C, De Jonghe P, Marttila M, Laing NG, Pelin K, Wallgren-Petterson C (2007) Cap disease caused by heterozygous deletion of the β- tropomyosin gene TPM2. Neuromuscular Disorders 17 (6) : 433-442. (IF = 2.615)
Maex R., De Schutter E., Mechanism of spontaneous and self-sustained oscillations in networks connected through axo-axonal gap junctions. Eur J. Neurosci. 25 (11): 3347-58 (2007). (IF = 3.709)
Mariën P., J. Verhoeven, R. Brouns, L. De Witte, A. Dobbeleir, P.P. De Deyn. Apraxic agraphia following a right cerebellar hemorrhage. Neurology 69 (9): 926-929 (2007). (IF = 5.690)
Miltenberger-Miltenyi G., Janecke A.R., Wanschitz J., Timmerman V., Windpassinger C., Auer-Grumbach M., Löscher W.L. (2007) Clinical and electrophysiological features in CMT with mutations in the NEFL gene. Archives of Neurology, 64: 966-970. (IF = 5.204)
Nagels G., M.B. D´hooghe, L. Vleugels, D. Kos, M. Despontin, P.P. De Deyn. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J. Clin. Neurosci. 14: 33-40 (2007). (IF = 0.673)
Nagels G., S. Engelborghs, E. Vloeberghs, W. Lemmens, B.A. Pickut, P.P. De Deyn. Correlation between actigraphy and nurses´ observation of activity in dementia. Int. J. Geriatr. Psychiatry 22: 84-86 (2007). (IF = 1.930)
Rabinowitz J., I. Katz, P.P. De Deyn, A. Greenspan, H. Brodaty. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone. Int. Psychogeriatr. 19 (2): 227-240 (2007). (IF = 1.745)
Rademakers R., Sleegers K., Pals P., Lohmann E., Durr A., Engelborghs S., De Pooter T., Van den Broeck M., Camuzat A., Nuytemans K., Pickut B., Cruts M., De Deyn P.P., Cras P., Brice A., Van Broeckhoven C. High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson's disease susceptibility. American Journal of Human Genetics, 77: 643-652 (IF = 12.629)
Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B., Martin J-J, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R: Infantile presentation of the mitochondrial A8344G mutation. (2007) Letter to the Editor. European Journal of Neurology 14: e3-e5. (IF = 2.437)
Sevin C., L. Verot, A. Benraiss, D. Van Dam, G. Nagels, F. Fouquet, V. Gieselmann, M.T. Vanier, P.P. De Deyn, P. Aubourg, N. Cartier. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther. 14 (5): 405-415 (2007). (IF = 4.782)
Sheorajpanday R.V.A., P.P. De Deyn. Epileptic fits and epilepsy in the elderly: General reflections, specific issues and therapeutic implications. Clin. Neurol. Neurosurg. 109: 727-743 (2007). (IF = 1.506)
Shin S.L., Hoebeek F.E., Schonewille M., De Zeeuw C.I., Aertsen A., De Schutter E., Regular patterns in cerebellar Purkinje cell simple spike trains. PLoS ONE 2 (5): e485, 1-9 (2007). (IF = --)
Shin S.L., Rotter S., Aertsen A., De Schutter E., Stochastic description of complex and simple spike firing in cerebellar Purkinje cells. Eur. J. Neurosci. 25 (3): 785-94 (2007). (IF = 3.709)
Sleegers, K., Kumar-Singh, S., Cruts, M., Van Broeckhoven, C. Molecular pathogenesis of frontotemporal lobar degeneration. Archives of Neurology (Accepted for Publication) (IF = 5.204)
Sprigg N., L.J. Gray, P.M Bath, E. Lindenstrøm, G. Boysen, P.P. De Deyn, P. Friis, D. Leys, R. Marttila, J.E. Olsson, D. O´Neill, E.B. Ringelstein, J.J. van der Sande, A.G. Turpie, for the TAIST Investigators. Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ´Tinzaparin in Acute Ischaemic Stroke Trial´ (TAIST). J. Neurol. Sci. 254 (1-2): 54-59 (2007)
Sprigg N., L.J. Gray, P.M.W. Bath, E. Lindenstrøm, G. Boysen, P.P. De Deyn, P. Friis, D. Leys, R. Marttila, J.-E. Olsson, D. O´ Neil, E.B. Ringelstein, J.-J. van der Sande, A.G.G. Turpie for the TAIST Investigators. Early recovery and functional outcome are related with causal stroke subtype: data from the Tinzaparin in acute ischemic stroke trial. J. Stroke Cerebrovasc. Dis. 16 (4): 180-184 (2007)
Stendel, C., Roos, R., Deconinck, T, Pereira, J., Castagner, F., Niemann, A., Kirschner, J., Korinthenberg, R., Ketelsen, U-P., Battaloglu, E., Parman, Y., Nicholson, G., Ouvrier, R., Seeger, J., De Jonghe, P., Weis, J., Krüttgen, A., Rudnik-Schöneborn, S., Bergmann, C., Suter, U., Zerres, K., Timmerman, V., Relvas, J.B., Senderek, J. (2007) Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. American Journal of Human Genetics 81(1): 158-164 (IF = 12.629)
Steuber V., Mittmann W., Hoebeek F.E., Silver R.A., De Zeeuw C.I., Häusser M., De Schutter E., Cerebellar LTD and pattern recognition by Purkinje cells. Neuron. 54 (1): 121-36 (2007). (IF = 13.894)
Taes Y.E.C., B. Marescau, A. De Vriese, P.P. De Deyn, E. Schepers, R. Vanholder, J.R. Delanghe. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol. Dial. Transplant. 2007 Nov 29 (Epub ahead of print). (IF = 3.154)
Van Dam D., K. Coen, P.P. De Deyn. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alsheimer´s disease. Psychopharmacology 2007 Nov 16; (Epub ahead of print). (IF = 3.625)
van der Zee J., Le Ber I., S. Maurer-Stroh, S. Engelborghs, I. Gijselinck, A. Camuzat, N. Brouwers, R. Vandenberghe, K. Sleegers, D. Hannequin, B. Dermaut, J. Schymkowitz, D. Campion, P. Santens, J.J. Martin, L. Lacomblez, T. De Pooter, K. Peeters, M. Mattheijssens, M. Vercelletto, M. Van den Broeck, M. Cruts, P.P. De Deyn, F. Rousseau, A. Brice, C. Van Broeckhoven. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum. Mutat. 28 (4): 416 (2007). (IF = 6.473)
van Diest D., van Goethem J.W.M., Vercruyssen A., Jadoul C., Cras P., Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation? Clinical neurology and neurosurgery, 109 (1): 58-62 (2007). (IF = 1.506)
Vloeberghs E., Coen K., Van Dam D., De Deyn P.P. Validation of the APP23 model of Alzheimer´s disease through evaluation of risperidone treatment on aggressive behaviour. Arzneimittel - Forschung/Drug Res. In press Nov 9, 2007 (IF = 0.596)
Vloeberghs E., Van Dam D. , F. Franck, M. Staufenbiel, P.P. De Deyn. Mood and male sexual behaviour in the APP23 model of Alzheimer´s disease. Behav. Brain Res. 180: 146-151 (2007). (IF = 2.591)
Vloeberghs E., Van Dam D., Franck F., Serroyen J., Molenberghs G., Staufenbiel M, De Deyn P.P. Altered ingestive behaviour, weight changes and intact olfactory sense in an APP overexpression model. Behavioral Neuroscience In press (IF = 2.969)
Vroon A., Drukarch B., Bol J.G., Cras P., Brevé J.J., Allan S.M., Relton J.K., Hoogland P.V., Van Dam A.M., Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp. Gerontol. 42( 8): 762-71 (2007). (IF = 1.439)
Wollmer M.A., K. Sleegers, M. Ingelsson, C. Zekanowski, N. Brouwers, A. Maruszak, F. Brunner, K.D. Huynh, L. Kilander, R.M. Brundin, M. Hedlund, V. Giedraitis, A. Glaser, S. Engelborghs, P.P. De Deyn, E. Kapaki, M. Tsolaki, M. Daniilidou, D. Molyva, G.P. Paraskevas, D.R. Thal, M. Barcikowska, J. Kuznicki, L. Lannfelt, C. Van Broeckhoven, R.M. Nitsch, C. Hock, A. Papassotiropoulos. Associated study of cholesterol-related genes in Alzheimer´s disease. Neurogenetics 8 (3): 179-188 (2007). (IF = 4.250)
Wostyn P., K. Audenaert, P.P. De Deyn. Alzheimer´s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin. Neurol. Neurosurg. 2007 Nov 29 (Epub ahead of print). (IF = 1.506)
Lijst van publicaties IBB in 2006
Achard P, De Schutter E (2006) Complex parameter landscape for a complex neuron model. PLoS Comput Biol. 2006 Jul 21, 2(7):e94 (no I.F.)
Bai Y., Ianokova E., Pu Q., Ghandour K., Levinson R., Martin J.-J., Ceuterick-de Groote C., Mazanec R., Seeman P., Shy M.E., Li J. R69C mutation in P0 gene alters myelination and ion channel subtype. Archives of Neurology, in press. (I.F. 4.900)
Baillieux H, De Smet HJ, Lesage G, Paquier P, De Deyn PP, Marien P. (2006) Neurobehavioral alterations in an adolescent following posterior fossa tumor resection. Cerebellum, 5: 289-295. (I.F. 1.762)
Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S, Aarsland D. (2006) Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J Neurol Neurosurg Psychiatry, 77: 1136-1142. (I.F. 3.122)
Brouns R, De Surgeloose D, Neetens I, De Deyn PP. (2006) Fatal venous cerebral air embolism secondary to a disconnected central venous catheter. Cerebrovasc Dis., 21: 212-214. (I.F. 2.319)
Brouwers N., Sleegers K., Engelborghs S., Bogaerts V., Serneels S., Kamali K., Corsmit E., De Leenheir E., Martin J.-J., De Deyn P.P., Van Broeckhoven C., Theuns J. (2006) Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain, 129: 2984-2991. (I.F. 7.535)
Brouwers N., Sleegers K., Engelborghs S., Bogaerts V., van Duijn C.M., De Deyn P.P., Van Broeckhoven C., Dermaut B. (2006) The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer´s disease with onset before 70 years. Neuroscience Letters, 392: 72-74. (I.F. 1.898)
Bruylant K, Crols R, Humbel RL, Appel B, De Deyn PP. (2006) Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. Clin Neurol Neurosurg., 108: 415-417. (I.F. 1.089)
Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R.. (2006) Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson´s disease. Mov Disord., 21: 1899-1907. (I.F. 2.830)
Burns A, De Deyn PP. (2006) Risperidone for the treatment of neuropsychiatric features in dementia. Drugs Aging, 23: 887-896. (I.F. 2.072)
Cromphout K, Vleugels W, Heykants L, Schollen E, Keldermans L, Sciot R, D´Hooge R, De Deyn PP, von Figura K, Hartmann D, Korner C, Matthijs G. (2006) The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development. Mol Cell Biol., 26: 5621-5635. (I.F. 7.093)
Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.-J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 442: 920-924. (I.F. 29.273)
De Deyn PP, Buitelaar J. (2006) Risperidone in the management of agitation and aggression associated with psychiatric disorders. Eur Psychiatry, 21: 21-28. (I.F. 1.273)
De Schutter E, Ascoli GA, Kennedy DN (2006) On the future of the Human Brain Project. Neuroinformatics 4: 129-130 (I.F. 3.902)
De Vriese A., Van Coster R., Smet J., Seneca S., Lovering A., Van Haute L.L., Vanopdenbosch L.J., Martin J.-J., Ceuterick-de Groote C., Vandecasteele S., Boelaert J.R. (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clinical Infectious Diseases, 42: 1111-1117. (I.F. 6.510)
De Witte L, Wilssens I, Engelborghs S, De Deyn PP, Marien P. (2006) Impairment of syntax and lexical semantics in a patient with bilateral paramedian thalamic infarction. Brain Lang., 96: 69-77. (I.F. 2.129)
D'Hulst C., De Geest N., Reeve S.P., Van Dam D., De Deyn P.P., Hassan B.A., Kooy R.F. (2006) Decreased expression of the GABA(A) receptor in fragile X syndrome. Brain Research, 1121: 238-245. (I.F. 2.296)
Dierckx E., Engelborghs S., De Raedt R., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? International Psychogeriatrics, submitted. (I.F. 1.215)
Dierckx E., Engelborghs S., De Raedt R., Maertens K., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between Mild Cognitive Impairment, Alzheimer´s disease and depression by means of cued recall. Psychological Medicine, 2006 Dec 13, Epub ahead of print. (I.F. 3.476)
Dierckx E., Engelborghs S., De Raedt R., Van Buggenhout M., De Deyn P.P., D´Haenens E., Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer´s disease and elderly depression. Journal of Clinical and Experimental Neuropsychology, submitted. (I.F. 1.689)
Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine A., Factor S.A., Ferrarese C., Hadjigeorgiou G., Higgings D., Kawakami H., Krüger R., Marder K., Mayeux R., Mellick G.D., Nutt J., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Myers R., Southwick A., Trikalinos T.A. (2006) Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurology, 5: 917-923. (I.F. 11.231)
Engelborghs S., De Vreese K., Van de Casteele T., Vanderstichele H., Van Everbroeck B., Cras P., Martin J.J., Vanmechelen E., De Deyn P.P. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiology of Aging, submitted. (I.F. 5.312)
Engelborghs S., Dermaut B., Mariën P., Symons A., Vloeberghs E., Maertens K., Somers N., Goeman J., Rademakers R., Van den Broeck M., Pickut B.A., Cruts M., Van Broeckhoven C., De Deyn P.P. (2006) Dose dependent effect of APOE 4 on behavioral symptoms in frontal lobe dementia patients. Neurobiology of Aging, 27: 285-292. (I.F. 5.312)
Engelborghs S., Maertens K., Mariën P., Vloeberghs E., Somers N., Nagels G., De Deyn P.P. (2006) Behavioural and neuropsychological correlates of frontal lobe features in dementia. Psychological Medicine, 36: 1173-1182. (I.F. 3.476)
Engelborghs S., Maertens K., Vloeberghs E., Aerts T., Somers N., Mariën P., De Deyn P.P. (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochemistry International, 48: 286-295. (I.F. 2.994)
Engelborghs S., Sleegers K., Cras P., Brouwers N., Serneels S., De Leenheir E., Martin J.-J., Vanmechelen E., Van Broeckhoven C., De Deyn P.P. No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer´s disease. Brain, submitted. (I.F. 7.535)
Errijgers V, Van Dam D, Gantois I, Van Ginneken CJ, Grossman AW, D´Hooge R, De Deyn PP, Kooy F (2006) FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis. Genes Brain Behav., 2006 Nov 3, Epub ahead of print. (I.F. 4.091)
Franken S, Wittke D, Mansson JE, D´Hooge R, De Deyn PP, Lullmann-Rauch R, Matzner U, Gieselmann V. (2006) Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene. Lipids Health Dis., 5:21. (no I.F.)
Gray LJ, Sprigg N, Bath PM, Sorensen P, Lindenstrom E, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O´Neill D, Ringelstein B, van der Sande JJ, Turpie AG; TAIST Investigators. (2006) Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry,.77: 327-333. (I.F. 3.122)
Hofmann UG, A Folkers, F. Mösch, T. Malina, K.M.L. Menne, G. Biella, P. Fagerstedt, E. De Schutter, W. Jensen, K. Yoshida, D. Hoehl, U. Thomas, M.G. Kindlundh, P. Norlin, M. de Curtis (2006) A novel high channel-count system for acute multi-site neuronal recordings. IEEE Transactions on Biomedical engineering 53: 1672-1677 (I.F. 1.857)
Irobi J, Dierick I, Jordanova A, Claeys KG, De Jonghe P, Timmerman V. (2006) Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Medicine, 8: 131-146. (I.F. 4.070)
Ivanova N., Löfgren A., Tournev I., Rousev R., Andreeva A., Jordanova A., Georgieva V., Deconinck T, Timmerman V., Kremensky I., De Jonghe P., Mitev V. (2006) Spastin gene mutations in Bulgarian patientswith hereditary spastic paraplegia. Clinical Genetics, 70: 490-495. (I.F. 3.276)
Kumar-Singh S., Theuns J., Van Broeck B., Pirici D., Vennekens K., Corsmit E., Cruts M., Dermaut B., Wang R., Van Broeckhoven C. (2006) Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Human Mutation, 27: 686-695. (I.F. 7.923)
Le Bastard N., Van Buggenhout M., de Leenheir E., Martin J.-J., De Deyn P.P., Engelborghs S. Low specificity limits the use of the cerebrospinal fluid A?1-42/P-tau181P ratio to discriminate Alzheimer´s disease from vascular dementia. Journal of Gerontology: Medical Sciences, in press. (I.F. 3.500)
Leergaard TB, Lillehaug S, De Schutter E, Bower JM, Bjaalie JG (2006) Topographical organization of pathways from somatosensory cortex through the pontine nuclei to tactile regions of the rat cerebellar hemispheres. European Journal of Neuroscience 24: 2801-2812 (I.F. 3.949)
Lupski J.R., Timmerman V. (2006) The CMT1A duplication: A historical perspective viewed from two sides of an ocean. In: Chapter 1 In: Genomic Disorders: The Genomic Basis of Disease Edited by J.R. Lupski and P. Stankiewicz (Humana Press, Totowa, N.J., USA.): 3-17. (no I.F.)
Marien P, Verhoeven J, Engelborghs S, Rooker S, Pickut BA, De Deyn PP. (2006) A role for the cerebellum in motor speech planning: evidence from foreign accent syndrome. Clin Neurol Neurosurg., 108: 518-522. (I.F. 1.089)
Miltenberger-Miltenyi G., Janecke A.R., Wanschitz J., Timmerman V., Windpassinger C., Auer-Grumbach M., Löscher W.L. : Clinical and electrophysiological features in CMT with mutations in the NEFL gene. Archives of Neurology, accepted for publication. (I.F. 4.900)
Nagels G. *, Engelborghs S. *, Vloeberghs E., Van Dam D., Pickut B.A., De Deyn P.P. (2006) Actigraphic measurement of agitated behaviour in dementia. International Journal of Geriatric Psychiatry, 21: 388-393 (* both first authors contributed equally to this paper). (I.F. 2.160)
Pals P., Bogaerts V., Rademakers R., De Pooter T., Bel Kacem S., Cruts M., Cras P., Van Broeckhoven C. Interaction between UCHL1 and pesticide exposure in Parkinson´s disease patients. Annals of Neurology, Submitted. (I.F. 7.571)
Pirici D., Vandenberghe R., Rademakers R., Dermaut B., Cruts M., Vennekens K., Cuijt I., Lubke U., Ceuterick C., Martin J.-J., Van Broeckhoven C., Kumar-Singh S. (2006) Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. Journal of Neuropathology and Experimental Neurology, 65: 289-301. (I.F. 4.471)
Rademakers R., Sleegers K., Pals P., Lohmann E., Durr A., Engelborghs S., De Pooter T., Van den Broeck M., Camuzat A., Nuytemans K., Pickut B., Cruts M., De Deyn P.P., Cras P., Brice A., Van Broeckhoven C. High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson's disease susceptibility. American Journal of Human Genetics (Under Review) (I.F. 12.649)
Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE, Abdalla M; 056 Study Group. (2006) Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord., 21: 1844-1850. (I.F. 2.830)
Santamaria F. , Wils S, De Schutter E, Augustine GJ (2006) Anomalous diffusion in Purkinje cell dendrites caused by dendritic spines. Neuron 52: 635-648 (I.F. 14.304)
Sevin C., Benraiss A., Van Dam D., Bonnin D., Nagels G., Verot L., Laurendeau I., Vidaud M., Gieselmann V., Vanier M., De Deyn P.P., Aubourg P., Cartier N. (2006) Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Human Molecular Genetics, 15: 53-64. (I.F. 7.764)
Sevin C., Verot L., Benraiss A., Van Dam D., Bonnin D., Nagels G., Fouquet F., Gieselmann V., Vanier M.T., De Deyn P.P., Aubourg P., Cartier N. (2006) Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Therapy, 2006 Nov 9; [Epub ahead of print]. (I.F. 4.836)
Sheorajpanday R, Slabbynck H, Van De Sompel W, Galdermans D, Neetens I, De Deyn PP. (2006) Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy. J Neuroophthalmol., 26: 168-172. (I.F. 0.976) Shin S-L, De Schutter E (2006) Dynamic synchronization of Purkinje cell simple spikes. Journal of Neurophysiology, 96: 3485-3491 (I.F. 3.853)
Solinas SMG, R. Maex, De Schutter (2006) Dendritic Amplification of Inhibitory Postsynaptic Potentials in a Model Purkinje Cell. European Journal of Neuroscience, 23: 1207-1218 (I.F. 3.949)
Sprigg N, Gray LJ, Bath PM, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O'Neill D, Ringelstein B, van der Sande JJ, Lindenstrom E; TAIST Investigators. (2006) Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens., 24: 1413-1417. (I.F. 5.218)
Theuns J., Brouwers N., Engelborghs S., Sleegers K., Bogaerts V., Corsmit E., De Pooter T., van Duijn C.M., De Deyn P.P., Van Broeckhoven C. (2006) Promoter mutations that increase amyloid precursor protein expression are associated with Alzheimer's disease. American Journal of Human Genetics, 78: 936-946. (I.F. 12.649)
Timmerman V., Lupski J.R. (2006) The CMT1A duplication and HNPP deletion. In: Chapter 11 In: Genomic Disorders: The Genomic Basis of Disease Edited by J.R. Lupski and P. Stankiewicz (Humana Press, Totowa, N.J., USA.): 169-178. (no I.F.)
Timmerman V., Lupski J.R., De Jonghe P. (2006) Molecular genetics, biology, and therapy for inherited peripheral neuropathies. Neuromolecular Medicine, 8: 1-2. (I.F. 4.070)
Torremans A., Marescau B., Kranzlin B., Gretz N., Billiouw J.M., Vanholder R., De Smet R., Bouwman K., Brouns R., De Deyn P.P. (2006) Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Kidney International, 69: 2003-2012. (I.F. 4.927)
Van Broeck B., Vanhoutte G., Pirici D., Van Dam D., Wils H., Cuijt I., Vennekens K., Zabielski M., Michalik A., Theuns J., De Deyn P.P., Van der Linden A., Van Broeckhoven C., Kumar-Singh S. (2006) Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiology of Aging, 2006 Nov 15; [Epub ahead of print]. (I.F. 5.312)
Van Broeckhoven C., Kumar-Singh S. (2006) Genetics and pathology of alpha-secretase site APP mutations in the understanding of Alzheimer's disease. Journal of Alzheimer's Disease, 9: 389-398. (no I.F.)
Van Dam D, Lenders G, De Deyn PP. (2006) Effect of Morris water maze diameter on visual-spatial learning in different mouse strains. Neurobiol Learn Mem., 85: 164-172. (I.F. 4.091)
Van Dam D., De Deyn P.P. (2006) Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. European Neuropsychopharmacology, 16: 59-69. (I.F. 3.510)
Van Dam D., De Deyn P.P. (2006) Drug discovery in dementia: the role of rodent models. Nature Reviews Drug Discovery, 5: 956-970. (I.F. 18.775)
Van Den Bosch L, Timmerman V. (2006) Genetics of motor neuron disease. Current Neurology and Neuroscience Reports, 6: 423-431. (no I.F. )
van der Zee J., Rademakers R., Engelborghs S., Gijselinck I., Bogaerts V., Vandenberghe R., Santens P., Caekebeke J., De Pooter T., Peeters K., Lubke U., Van den Broeck M., Martin J.-J., Cruts M., De Deyn P.P., Van Broeckhoven C., Dermaut B. (2006) A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain, 129: 841-852. (I.F. 7.535)
Van Everbroeck B., Michotte A., Sciot R., Godfraind C., Deprez M., Quoilin S., Martin J.-J., Cras P. (2006) Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium. European Journal of Epidemiology, 21: 443-447. (I.F. 1.361)
van Leeuwen F.W., van Tijn P., Sonnemans M.A., Hobo B., Mann D.M., Van Broeckhoven C., Kumar-Singh S., Cras P., Leuba G., Savioz A., Maat-Schieman M.L., Yamaguchi H., Kros J.M., Kamphorst W., Hol E.M., de Vos R.A., Fischer D.F. (2006) Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. Neurology, 66: S86-S92. (I.F. 5.056)
Verhoeven K., Claeys K., Züchner S., Schröder J.M., Ceuterick C., Jordanova A., Nelis E., De Vriendt E., Van Hul M., Seeman P., Mazanec R., Saifi M., Szigeti K., Mancia P., Butler I.J., Kochanski A., Ryniewicz B., De Bleecker J., Van den Bergh P., Verellen C., Van Coster R., Goemans N., Auerbach-Grumbach M., Robberecht W., Milic Rasic V., Nevo Y., Tournev I., Guergueltcheva V., Roelens F., Vieregge P., Vinci P., Moreno M.T., Christen H.J., Shy M.E., Lupski J.R., Vance J.M., De Jonghe P., Timmerman V. (2006) Mitofusin 2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain, 129: 2093-2102. (I.F. 7.535)
Verhoeven K., Timmerman V., Mauko B., Pieber T.R., De Jonghe P., Auer-Grumbach M. (2006) Recent advances in hereditary sensory and autonomic neuropathies. Current Opinion in Neurology, 19: 474-480. (I.F. 4.873)
Verpoorten N., Claeys K.G., Deprez L., Jacobs A., Van Gerwen V., Lagae L., Arts W.F., De Meirleir L., Ceuterick-de Groote C., De Jonghe P., Timmerman V., Nelis E. (2006) Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. Neuromuscular Disorders, 16: 19-25.(I.F. 3.340)
Verpoorten N., De Jonghe P., Timmerman V. (2006) Disease mechanisms in hereditary sensory and autonomic neuropathies. Neurobiology of Disease, 21: 247-255. (I.F. 4.048)
Verslegers WR, De Deyn PP. (2006) [Serious intoxication after inhaling methanol] Ned Tijdschr Geneeskd, 150: 2057. Dutch. No abstract available. (no I.F.)
Verslegers WR, Pickut BA, De Deyn PP. (2006) Paroxysmal neuralgic upper cervical pain attacks: the lower syndrome of cluster headache. Clin Neurol Neurosurg., 108: 737-743. (I.F. 1.089)
Vloeberghs E, Van Dam D, Coen K, Staufenbiel M, De Deyn PP. (2006) Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci. 120: 1380-1383. (I.F. 3.071)
Vloeberghs E., Van Dam D., D'Hooge R., Staufenbiel M., De Deyn P.P. (2006) APP23 mice display working memory impairment in the plus-shaped water maze. Neuroscience Letters, 407: 6-10. (I.F. 1.898)
Willekens BM, Rooker S, Dua G, Appel B, Martin JJ, Crols R, De Deyn PP. (2006) Central nervous system metastases of pulmonary adenocarcinoma mimicking neurofibromatosis type 2. Acta Neurol Belg., 106: 87-89. (I.F. 0.443)
Wouters M., De Laet A., Donck L.V., Delpire E., van Bogaert P.P., Timmermans J.P., de Kerchove d'Exaerde A., Smans K., Vanderwinden J.M. (2006) Active hybridization unravels a role for the ion cotransporter NKCC1 in the murine intestinal pacemaker. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290: G1219-G1227. (I.F. 3.472)
Lijst van publicaties IBB in 2005
Belhocine T, Weiner SM, Brink I, De Deyn PP, Roland J, Van der Borght T, Flamen P. A plea for the elective inclusion of the brain in routine whole-body FDG PET. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):251-6. (I.F. 3.935)
Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, Martin JJ, Laporte J, Lochmuller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P (2005). Mutations in dynamin 2 cause dominant centronuclear myopathy. Nature Genetics 37: 1207-1209. (I.F. 24.695)
De Deyn P, Jeste DV, Swanink R, Kostic D, Breder C, Carson WH, Iwamoto T. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study. J Clin Psychopharmacol. 2005 Oct;25(5):463-7. (I.F. 4.419)
De Deyn PP*, Engelborghs S*, Saerens J, Goeman J, Marien P, Maertens K, Nagels G, Martin JJ, Pickut BA. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer´s disease. Int J Geriatr Psychiatry. 2005 Jan;20(1):70-9 (* both first authors contributed equally to this work). (I.F. 1.971)
De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. (I.F. 0.954)
De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL (2005). Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. Acta Neuropathol (Berl) 109: 576-582. (I.F. 2.503)
Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int. 2005 Apr;67(4):1566-75. (I.F. 4.790)
Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Marien P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005 Nov;20(11):1028-37. (I.F. 1.971)
Hakonen, A.H., Heiskanen,S., Juvonen,V., Lappalainen,I., Luoma,P.T., Rantamäki,M., Van Goethem,G., Löfgren,A., Hackman,P., Paetau,A., Kaakkola,S., Majamaa,K., Varilo,T., Udd,B., Kääriäinen,H., Bindoff,L.A., Suomalainen,A.: Mitochondrial DNA polymerase W748S mutation: A new common cause of autosomal recessive ataxia with ancient European origin. American Journal of Human Genetics (Accepted for Publication) (I.F.: 12.34)
Jorens PG, Parizel PM, Demey HE, Smets K, Jadoul K, Verbeek MM, Wevers RA, Cras P (2005) Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids. Neuroradiology 47(10):758-64. (I.F. 1.515)
Kumar-Singh,S., Dickson,D., Pirici,D.N., Serneels,S., Ceuterick,C., McGowan,E., Duff,K., Hardy,J., Van Broeckhoven,C.: Dense-core plaques in Alzheimer´s mice are derived from vascular walls. American Journal of Pathology 167(2): 527-543 (2005) (I.F.: 6.441)
Laing NG, Ceuterick-de Groote C, Dye DE, Liyanage K, Duff RM, Dubois B, Robberecht W, Sciot R, Martin JJ, Goebel HH (2005). Myosin storage myopathy: slow skeletal myosin (MYH7) mutation in two isolated cases. Neurology 64: 527-529. (I.F. 5.973) Mariën P, Abutalebi J, Engelborghs S, De Deyn PP. Pathophysiology of language switching and mixing in an early bilingual child with subcortical aphasia. Neurocase. 2005 Dec;11(6):385-98. (I.F. 0.978)
Mariën P, Brouns R, Engelborghs S, Wackenier P, Verhoeven J, Ceulemans B, De Deyn PP. Cerebellar cognitive affective syndrome in two relatives with Gillespie syndrome. Cortex, in press. (I.F. 2.472)
Nagels G, Geentjens L, Kos D, Vleugels L, D'hooghe MB, Van Asch P, Vuylsteke K, De Deyn PP. Paced visual serial addition test in multiple sclerosis. Clin Neurol Neurosurg. 2005 Apr;107(3):218-22. (I.F. 0.954)
Niessen P., Rensen S., van Deursen J., De Man J., De Laet A.,Vanderwinden J.-M., Wedel T., Baker D., Doevendans P., Hofker M.,Gijbels M., van Eys G. Smoothelin-A is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 129(5):1592-1601 (2005). (I.F. 13.092)
Petersen RB, Siedlak SL, Lee HG, Kim YS, Nunomura A, Tagliavini F, Ghetti B, Cras P, Moreira PI, Castellani RJ, Guentchev M, Budka H, Ironside JW, Gambetti, P, Smith MA, Perry G. (2005) Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (Berl) 110(3):232-8. (I.F. 2.503)
Pirici D, van der Zee J, Rademakers R, Dermaut B, Cruts M, Lübke U, Ceuterick C, Martin J-J, Vandenberghe R, Van Broeckhoven C, Kumar-Singh S. Clinical, genetic and neuropathological description of a Belgian FTD family with ubiquitin-positive, tau-negative inclusions (FTD-U). Accepted in J Neuropathol Exp Neurol. (I.F. 5.037)
Pittoors F., van Bogaert P.P. "Inactivation" of mHCN2 expressed in oocytes. Eur J Physiology 449: R7 (2005). Rabinowitz J, Davidson M, De Deyn PP, Katz I, Brodaty H, Cohen-Mansfield J. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance. Am J Geriatr Psychiatry. 2005 Nov;13(11):991-8. (I.F.: 3.469)
Rademakers,R., Melquist,S., Cruts,M., Theuns,J., Del-Favero,J., Poorkaj,P., Baker,M., Sleegers,K., Crook,R., De Pooter,T., Bel Kacem,S., Adamson,J., Van den Bossche,D., Van den Broeck,M., Gass,J., Corsmit,E., De Rijk,P., Thomas,N., Engelborghs,S., Heckman,M., Crook,J., De Deyn,P.P., Dickson,D., Schellenberg,G., Van Broeckhoven,C., Hutton,M.L.: High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Human Molecular Genetics 14(21): 3281-3292 (2005) (I.F.: 7.801)
Rademakers,R., Sleegers,K., Pals,P., Lohmann,E., Durr,A., Engelborghs,S., De Pooter,T., Van den Broeck,M., Camuzat,A., Nuytemans,K., Pickut,B., Cruts,M., De Deyn,P.P., Cras,P., Brice,A., Van Broeckhoven,C.: High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson´s disease susceptibility. American Journal of Human Genetics (Under Review) (I.F.: 12.34)
Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005 Nov;20(7):490-6. Epub 2005 Jan 27. (I.F.: 1.191)
Sindic CJ, Seeldrayers P, Vande Gaer L, De Smet E, Nagels G, De Deyn PP, Medaer R, Guillaume D, D'Hooghe MB, Deville MC, Decoo D, Sadzot B, Van Landegem W, Strauven T, Pepin J, Merckx H, Caekebeke J, van der Tool MA. Long-term follow up of glatiramer acetate compassionate use in Belgium. Acta Neurol Belg. 2005 Jun;105(2):81-5. (I.F.: 0.380)
Smets K, R. salgado, P.J. Simons, R. Declercq, K. De Smedt, P. Cras (2005) Central neurocytoma presenting with intraventricular hemorrhage: case report and review of the litterature. Acta Neurol Belg 105: 218-225. (I.F.: 0.380)
Torremans A, Marescau B, Possemiers I, Van Dam D, D'Hooge R, Isbrandt D, De Deyn PP. Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. J Neurol Sci. 2005 Apr 15;231(1-2):49-55. (I.F.: 2.366)
Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP. GSA: behavioral, histological, electrophysiological and neurochemical effects. Physiol Behav. 2005 Feb 15;84(2):251-64. (I.F.: 2.044)
Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology (Berl). 2005 Jun;180(1):177-90. (I.F.: 3.146)
Van Dam D, Errijgers V, Kooy RF, Willemsen R, Mientjes E, Oostra BA, De Deyn PP. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav Brain Res. 2005 Jul 30;162(2):233-9. (I.F.: 2.992)
Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP. Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids. 2005 Jun;28(4):377-87. Epub 2005 May 17. (I.F.: 2.000)
Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochem Int. 2005 Apr;46(5):409-22. (I.F.: 3.211)
Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder. CNS Spectr. 2005 Mar;10(3):207-22. Review.
Van Everbroeck B, Boons J, Cras P. (2005) 14-3-3 {gamma}-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias. J Neurol Neurosurg Psychiatry 76(1):100-2. (I.F.: 3.110)
Van Everbroeck, B., J. Boons, P. Cras (2005) Cerebrospinal fluid markers in Creutzfeldt-Jakob´s disease. Clin Neurol Neurosurg 107(5):355-60. (I.F.: 0.954)
Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S; GAL-INT-28 Study Group. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. Curr Med Res Opin. 2005 Sep;21(9):1423-9. (I.F.: 2.928)
Verhoeven J, Mariën P, Engelborghs S, D´Haenen H, De Deyn PP. A foreign speech accent in a case of conversion disorder. Behav Neurol, in press. (I.F.: 1.158)
Verpoorten N, Verhoeven K, Weckx S, Jacobs A, Serneels S, Del Favero J, Ceuterick C, Van Bockstaele DR, Berneman ZN, Jordaens K, Van Den Bosch L, Robberecht W, Nobbio L, Schenone A, Dessaud E, deLapeyrière O, Huylebroeck D, Zwijsen A, De Jonghe P, Timmerman V (2005). Synpatopodin and 4 novel genes identified in primary sensory neurons. Molecular and Cellular Neuroscience 30: 316-325. (I.F.: 3.789)
Verpoorten,N., Claeys,K.G., Deprez,L., Jacobs,A., Van Gerwen,V., Lagae,L., Arts,W.F., De Meirleir,L., Ceuterick,C., De Jonghe,P., Timmerman,V., Nelis,E.: Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. Neuromuscular Disorders (Accepted for Publication) (I.F.: 3.042)
Verpoorten,N., Verhoeven,K., Weckx,S., Jacobs,A., Serneels,S., Del-Favero,J., Ceuterick,C., Van Bockstaele,D.R., Berneman,Z.N., Jordaens,K., Van Den Bosch,L., Robberecht,W., Nobbio,L., Schenone,A., Dessaud,E., deLapeyrière,O., Huylebroeck,D., Zwijsen,A., De Jonghe,P., Timmerman,V.: Synaptopodin and 4 novel genes identified in primary sensory neurons. Molecular and Cellular Neuroscience 30(3): 316-325 (2005) (I.F.: 3.789)
Wouters M., De Laet A., Ver Donck L., Delpire L., Van Bogaert P.P., Timmermans J.-P., de Kerchove d´Exaerde A., Smans K., Vanderwinden J.-M. Subtractive hybridization unravels a role for the ion co-transporter NKCC1 in the murine intestinal pacemaker. American J Physiology-Gastrointestinal and Liver Physiology ( abstract on line beschikbaar August 25,2005; in press). (I.F.: 3.479)
Wuyts W, Reyniers E, Ceuterick C, Storm K, de Barsy T, Martin JJ (2005). Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A. 133A: 82-84. (I.F.: 3.659)